In this manuscript, COVID-19, Ebola virus disease, Nipah virus infection, SARS, and MERS are suggested to be considered for a novel immunological reclassification as acute onset immune dysrhythmia syndrome (n-AIDS) due to altered monocytic, Th1/Th2, as well as cytokines and chemokines balances. n-AIDs is postulated to be the cause of the acute respiratory distress and multi-inflammatory syndromes which are described with fatal COVID-19, and immunomodulators are suggested to effectively manage the mentioned diseases as well as for other disorders caused by Th1/Th2 imbalance. Meanwhile, para COVID syndrome is suggested to describe various immune-related complications, whether before or after recovery, and to embrace a potential of a latent infection, that might be discovered later, as occurred with Ebola virus disease. Finally, our hypothesis has evolved out of our real-life practice that uses immunomodulatory drugs to manage COVID-19 safely and effectively.

在这份手稿中，建议考虑将 COVID-19、埃博拉病毒病、尼帕病毒感染、SARS 和 MERS 进行新的免疫学重新分类为急性发作性免疫节律失常综合征 (n-AIDS)，原因是单核细胞、Th1/Th2、以及细胞因子和趋化因子的平衡。n-AID 被认为是致命的 COVID-19 描述的急性呼吸窘迫和多发性炎症综合征的原因，建议使用免疫调节剂来有效控制上述疾病以及由 Th1/Th2 失衡引起的其他疾病. 同时，建议用 para COVID 综合征来描述各种与免疫相关的并发症，无论是在康复之前还是之后，并包含潜在的感染，这种感染可能会在以后发现，就像埃博拉病毒病一样。最后，